Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

55 та иш

Иш: Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment

  1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram +3

    Мақола201834 иқтибос
    ABI

  2. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide

    Xiaopeng Mo, Zening Zheng, Yang He +6

    Мақола20185 иқтибос
    ABI

  3. Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

    Pengfei Zhao, Yonghui Wang, Xuejia Kang +7

    Мақола20184 иқтибос
    ABI

  4. Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

    Weimin Yin, Xiaolu Yu, Xuejia Kang +7

    Мақола20184 иқтибос
    ABI

  5. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

    Douglas Hanahan, Lisa M. Coussens

    Шарҳ мақола20124 иқтибос
    ABI

  6. Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

    Huige Peng, Binfan Chen, Wei Huang +4

    Мақола20173 иқтибос
    ABI

  7. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

    Hongyue Jin, Yang He, Pengfei Zhao +4

    Мақола20183 иқтибос
    ABI

  8. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

    Binfan Chen, Ang Gao, Bin Tu +7

    Мақола20203 иқтибос
    ABI

  9. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

    Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar +2

    Шарҳ мақола20183 иқтибос
    ABI

  10. Immune suppressive mechanisms in the tumor microenvironment

    David H. Munn, Vincenzo Bronte

    Шарҳ мақола20153 иқтибос
    ABI

  11. Targeting macrophages: therapeutic approaches in cancer

    Luca Cassetta, Jeffrey W. Pollard

    Шарҳ мақола20183 иқтибос
    ABI

  12. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan

    W Chen, J Wang, Lianqun Jia +2

    Мақола20162 иқтибос
    ABI

  13. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

    Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera +11

    Мақола20172 иқтибос
    ABI

  14. Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

    Bin Tu, Meng Zhang, Tuanbing Liu +1

    Шарҳ мақола20202 иқтибос
    ABI

  15. Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery

    Mustafa M.A. Elsayed, Ossama Y. Abdallah, Viviane F. Naggar +1

    Мақола20062 иқтибос
    ABI

  16. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

    Sean B. Joseph, Antonio Castrillo, Bryan Laffitte +2

    Мақола20032 иқтибос
    ABI

  17. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

    Graziella Solinas, Giovanni Germano, Alberto Mantovani +1

    Шарҳ мақола20092 иқтибос
    ABI

  18. VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer

    Magali Terme, Simon Pernot, Elie Marcheteau +7

    Мақола20122 иқтибос
    ABI

  19. Epigenetic Therapeutics: A New Weapon in the War Against Cancer

    Nita Ahuja, Anup Sharma, Stephen B. Baylin

    Шарҳ мақола20162 иқтибос
    ABI

  20. BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR<sup>T790M</sup> mutation

    Weimin Yin, Yuge Zhao, Xuejia Kang +5

    Мақола20202 иқтибос
    ABI

  21. Macrophage targeting in cancer

    Martha Lopez‐Yrigoyen, Luca Cassetta, Jeffrey W. Pollard

    Шарҳ мақола20202 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI